Immunology Section News Today

Gifted physician, researcher and professor brought laughter and brightness to all who knew him

Ramat Gan hospital to work with NIH for the quick identification of emerging pathogens and rapid deployment of scientific tools to fight them

Poppy Jones, pictured, suffered a near-fatal reaction on board a flight from Antigua to Gatwick when a fellow passenger began eating a peanut, ignoring warnings about Poppys allergy.

Cleaning is good for your health, according to Dr. Caroline C. Aquino from the Department of Pediatrics, Allergology and Immunology Section of top hospital in the Philippines, Makati Medical Center (MakatiMed).

If you have been avoiding the chore of thoroughly cleaning up all year long, you are not alone. “Everybody has their reasons for putting off the task of clearing drawers, closets, and entire rooms of junk,” says Caroline C. Aquino, MD, from the Department of Pediatrics, Allergology and Immunology Section…

A booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months after their primary vaccine series significantly increased

Different mRNA-1273 boosters are equally protective against variants.

Phase 1 clinical trial of novel HIV vaccine approach shows promising results A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today. The vaccine showed success in stimulating production of rare immune cells needed to start the process of generating antibodies against the fast-mutating virus; the targeted response was detected in 97 percent of participants who received the vaccine. This study demonstrates...

Phase 1 Clinical Trial Confirms HIV Vaccine Approach by Angela Mohan on  February 4, 2021 at 11:12 AM Phase 1 clinical trial testing a novel vaccine against HIV has produced promising results, IAVI and Scripps Research announced. The vaccine showed success in stimulating production of rare immune cells needed to start the process of generating antibodies against the fast-mutating virus; the targeted response was detected in 97 percent of participants who received the vaccine....

Loading video... VIDEO: A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced. The vaccine showed success in stimulating production of... view more  Credit: Scripps Research NEW YORK and LA JOLLA, CA--A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today. The vaccine showed success in stimulating production of ...